Johns Hopkins ABX Guide
Spiramycin
INDICATIONS
FDA
FDA
- Spiramycin: not commercially available in the U.S.
- May be obtained as below (see Adult Dosing)
- Indicated for treating primary toxoplasmosis in pregnant women to prevent congenital toxoplasmosis (IgM titer needs to be confirmed by Dr. Jack S. Remington Laboratory for Specialty Diagnostics; T: 650-853-4828).
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Congenital toxoplasmosis
- Cryptosporidium
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: October 18, 2022
Citation
Dzintars, Kathryn, and Paul G Auwaerter. "Spiramycin." Johns Hopkins ABX Guide, The Johns Hopkins University, 2022. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540513/all/Spiramycin.
Dzintars K, Auwaerter PG. Spiramycin. Johns Hopkins ABX Guide. The Johns Hopkins University; 2022. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540513/all/Spiramycin. Accessed April 17, 2025.
Dzintars, K., & Auwaerter, P. G. (2022). Spiramycin. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540513/all/Spiramycin
Dzintars K, Auwaerter PG. Spiramycin [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2022. [cited 2025 April 17]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540513/all/Spiramycin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Spiramycin
ID - 540513
A1 - Dzintars,Kathryn,Pharm.D., BCPS
AU - Auwaerter,Paul,M.D.
Y1 - 2022/10/18/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540513/all/Spiramycin
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
